TR201109160A2 - New pharmaceutical compositions containing eplerenone. - Google Patents

New pharmaceutical compositions containing eplerenone.

Info

Publication number
TR201109160A2
TR201109160A2 TR2011/09160A TR201109160A TR201109160A2 TR 201109160 A2 TR201109160 A2 TR 201109160A2 TR 2011/09160 A TR2011/09160 A TR 2011/09160A TR 201109160 A TR201109160 A TR 201109160A TR 201109160 A2 TR201109160 A2 TR 201109160A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
compositions containing
new pharmaceutical
containing eplerenone
eplerenone
Prior art date
Application number
TR2011/09160A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/09160A priority Critical patent/TR201109160A2/en
Publication of TR201109160A2 publication Critical patent/TR201109160A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Mevcut buluş; eplerenon içeren yeni, çözünebilir ve kolay üretilebilir farmasötik formülasyonlar ile ilişkilidir.The present invention; relates to new, soluble and easily manufactured pharmaceutical formulations containing eplerenone.

TR2011/09160A 2010-09-20 2011-09-19 New pharmaceutical compositions containing eplerenone. TR201109160A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2011/09160A TR201109160A2 (en) 2010-09-20 2011-09-19 New pharmaceutical compositions containing eplerenone.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/07653A TR201007653A2 (en) 2010-09-20 2010-09-20 Pharmaceutical composition containing eplerenone
TR2011/09160A TR201109160A2 (en) 2010-09-20 2011-09-19 New pharmaceutical compositions containing eplerenone.

Publications (1)

Publication Number Publication Date
TR201109160A2 true TR201109160A2 (en) 2012-04-24

Family

ID=45524932

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2010/07653A TR201007653A2 (en) 2010-09-20 2010-09-20 Pharmaceutical composition containing eplerenone
TR2011/09160A TR201109160A2 (en) 2010-09-20 2011-09-19 New pharmaceutical compositions containing eplerenone.
TR2011/09159A TR201109159A2 (en) 2010-09-20 2011-09-19 Film-coated tablet composition containing eplerenone.
TR2011/09158A TR201109158A2 (en) 2010-09-20 2011-09-19 Easily soluble pharmaceutical composition containing eplerenone.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2010/07653A TR201007653A2 (en) 2010-09-20 2010-09-20 Pharmaceutical composition containing eplerenone

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2011/09159A TR201109159A2 (en) 2010-09-20 2011-09-19 Film-coated tablet composition containing eplerenone.
TR2011/09158A TR201109158A2 (en) 2010-09-20 2011-09-19 Easily soluble pharmaceutical composition containing eplerenone.

Country Status (2)

Country Link
TR (4) TR201007653A2 (en)
WO (1) WO2012050539A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109925293B (en) * 2019-03-15 2022-02-01 南京卡文迪许生物工程技术有限公司 Eplerenone oral solid preparation and preparation method thereof
CN113995719B (en) * 2021-10-19 2023-06-23 河南中盛生物工程有限公司 Application of sodium carboxymethyl cellulose in improving amoxicillin and colistin sulfate injection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77669C (en) 1983-04-13 1989-04-10 Ciba Geigy Ag 20-SPIROXANER OCH ANALOGER, SOM INNEHAOLLER EN OEPPEN RING E, FOERFARANDE FOER DERAS FRAMSTAELLNING SAMT DESSA INNEHAOLLANDE PHARMACEUTICAL PREPARATION.
UA74141C2 (en) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Oral pharmaceutical compositions comprising micronized eplerenone (variants), method for its production and method for treating aldosterone-mediated states (variants)
DE60019741T2 (en) 1999-12-08 2006-03-02 Pharmacia Corp., Chicago NANOPARTICLE COMPOSITIONS CONTAINING EPLERENONE
EP1280533A2 (en) * 2000-05-11 2003-02-05 Pharmacia Corporation Aldosterone antagonist composition for release during aldosterone acrophase
WO2007012960A1 (en) * 2005-07-29 2007-02-01 Glenmark Pharmaceuticals Limited Pharmaceutical compositions of eplerenone
US20100086586A1 (en) * 2006-12-21 2010-04-08 Brett Antony Mooney Pharmaceutical Composition

Also Published As

Publication number Publication date
TR201007653A2 (en) 2012-04-24
TR201109159A2 (en) 2012-04-24
WO2012050539A1 (en) 2012-04-19
TR201109158A2 (en) 2012-04-24

Similar Documents

Publication Publication Date Title
JOP20180102B1 (en) Pharmaceutical composition
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
EA201590887A1 (en) COMPOSITION
BR112012031226A2 (en) compound, compound use, pharmaceutical composition, and pharmaceutical composition use
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.
TR201905272T4 (en) Immunogenic composition.
TR201821285T4 (en) Pharmaceutical formulations containing a CCR3 antagonist.
BR112015002824A2 (en) compound, use of a compound, pharmaceutical composition, and combination pharmaceutical product.
TR201905787T4 (en) Lyophilized TAT-NR2B9C formulation.
TR201903918T4 (en) Compositions containing a dispersing agent and their preparation.
TR201100150A2 (en) Water soluble dosage forms
MY165088A (en) Pharmaceutical compositions comprising alisporivir
MX365429B (en) Flavor and fragrance formulation (i).
MX2015004314A (en) Flavor and fragrance formulation (iii).
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
TR201002878A2 (en) Pharmaceutical compositions comprising cefpodoxime proxetil.
WO2012093973A3 (en) Compositions in the form of tablets comprising acarbose
EP2569327A4 (en) Eif4e binding peptides
TR201007106A1 (en) Cefpodoxime proxetil formulations.
TR201109160A2 (en) New pharmaceutical compositions containing eplerenone.
TR201005327A2 (en) Synergistic pharmaceutical formulations.
TR201010859A2 (en) Tablet forms containing cefdinir.
TR201104864A2 (en) Water-soluble formulations containing dexketoprofen.
MX360017B (en) Flavor and fragrance formulation (iv).
TR201009165A2 (en) Tablets containing cefdinir